Share
ISSN: 0214-9168
Clínica e Investigación en Arteriosclerosis ha recibido Factor de Impacto (JCR) por primera vez en 2023.
Guía para autores
-
Envío de manuscritos
"Notas metodológicas": una nueva e importante sección en Clínica e Investigación en Arteriosclerosis
Indexed in:
Web of Science, Index Medicus/MEDLINE, Scopus, IBECS, IME, MEDES
See moreFollow us:
Subscribe:
Impact factor
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2022
Impact factor 2022
1.6
Citescore 2022
3
SJR
SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.
See moreSJR 2022
0.36
SNIP
SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.
See moreSNIP 2022
0.605
View more metrics
Hide
Journal Information
Highlighted articles
“Notas metodológicas”: una nueva e importante sección en Clínica e Investigación en Arteriosclerosis
Josep Ribalta, Carlos Lahoz, Xavier Pintó
Clin Invest Arterioscl. 2023;35:243
Open Article
Consenso sobre lipoproteína (a) de la Sociedad Española de Arteriosclerosis. Revisión bibliográfica y recomendaciones para la práctica clínica
Javier Delgado-Lista, Jose M. Mostaza, Teresa Arrobas-Velilla, Francisco Blanco-Vaca, Luis Masana, Juan Pedro-Botet, Pablo Perez-Martinez, Fernando Civeira, ... Carlos Guijarro
Open Article
Available online 10 April 2024
Publish in
Clínica e Investigación en Arteriosclerosis
Highlighted articles
Special content about COVID-19
- Thrombotic risk assessed by PAI-1 in patients with COVID-19: The influence of hyperglycemia and diabetes mellitus
- Absence of the influence of the APOE gene on the incidence of type 2 diabetes mellitus in a cohort of workers: Effect of diet and shift work
- Dietary modulation of advanced glycation end products metabolism on carotid intima-media thickness in type 2 diabetes patients: From the CORDIOPREV study
- Impacto de la pandemia por COVID-19 en el control lipídico de pacientes que inician inhibidores de la PCSK9
Free access articles
Clin Invest Arterioscl. 2024;36:80-5
Clin Invest Arterioscl. 2024;36:71-7
Clin Invest Arterioscl. 2023;35:243